Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Œsophage » Néoplasie

07. Octobre 2026

Dépistage / diagnostic

Recherche de documentation spécialisée

Troubles de la motilité

Écriture:

Page 1 de 1991


	Articles 1 - 20 / 39804

	Advancements in the clinical application of gene methylation for early cancer detection. Front Epigenet Epigenom Xu X, Guo Y, Liu M, Hu Y, Li S. PMID: 42840534 [PubMed]
	Five-Year Survival Analyses on Non-Pathological Complete Response Esophageal Squamous Cell Carcinoma Patients After Neoadjuvant Regimens Plus Surgery: A Propensity Score Matching, Real-World Cohort Study. Cancer Med Liu W, Deng Y, Lin Y, Lin Y, Zheng X, Su W, Xiao W, Shi Y, Zhang J, Chen X. PMID: 42839363 [PubMed - indexed for MEDLINE]
	Sensitivity and Specificity of Chest CT for Detection of Esophageal Cancer. Acad Radiol Siddiqui TA, Kaproth-Joslin K, Proffitt EK, Baran TM, Shiau MC. PMID: 42838881 [PubMed - as supplied by publisher]
	Thoracic Surgery Oncology Quality Indicators (Part 2: Thymic Epithelial Tumors and Esophageal Cancer). Thorac Surg Clin Plourde M, Chen A, Brownstone R. PMID: 42838627 [PubMed - indexed for MEDLINE]
	Trends and Projections of Esophageal Cancer Incidence and Mortality in China, 1990 to 2050: An Analysis of the Global Burden of Disease Study 2023. J Clin Gastroenterol Su P, Xu Y, Wen S, Lv H, Zhu Y, Wang H, Tian Z. PMID: 42837608 [PubMed - as supplied by publisher]
	Impact of PD-1 and PD-L1 inhibitors on patient-reported outcomes in esophageal squamous cell carcinoma: a systematic review of clinical trials. Curr Med Res Opin Choi SA, Wong WJ, Barnes FB, Buck PO, Allaire JC. PMID: 42836832 [PubMed - as supplied by publisher]
	Optimal Sequencing of First-Line Immune Checkpoint Inhibitors With Definitive Chemoradiotherapy: A Multicenter Real-World Cohort Study Comparing Induction, Concurrent, and Consolidation Strategies for Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma. Int J Cancer Zhao X, Wen S, Song C, Wang J, Zhang Y, Wang C, Liu Y, Qian P, Cao J, Hou Q, Xu Y, Lin Z, Ye X, Hou M, Gui Y, Wang L, Zhou W, Zeng Z, Song Y, Luo H, Lv J, Zhu S, Shen W. PMID: 42836385 [PubMed - as supplied by publisher]
	The Dual Role of Piezo1 in Cancer: Mechanotransduction, Microenvironment Remodelling, and Therapeutic Opportunities. Drug Des Devel Ther Jiang H, Liu Y, Xue F, Sun H, Ji Y, Qi L. PMID: 42836163 [PubMed - indexed for MEDLINE]
	First-line tislelizumab plus chemotherapy versus placebo plus chemotherapy in unresectable advanced/metastatic esophageal squamous cell carcinoma: minimum 3-year survival follow-up of a randomized phase 3 trial (RATIONALE-306). Nat Commun Yoon HH, Kato K, Raymond E, Hubner R, Shu Y, Pan Y, Park SR, Kojima T, Lin CY, Wyrwicz L, Tougeron D, Ishihara R, Wang K, Peng Y, Xu J. PMID: 42834033 [PubMed - indexed for MEDLINE]
	Development of a Multimodal AI Model to Predict the Efficacy of Photodynamic Therapy for Local Residual or Recurrent Lesions Following Chemoradiotherapy or Radiotherapy for Esophageal Cancer. Dig Endosc Nakajo K, Sasagawa Y, Tomino T, Hirose H, Imai A, Endo M, Yamashita H, Yamamoto M, Takemura H, Yano T. PMID: 42833664 [PubMed - indexed for MEDLINE]
	The prognostic impact of sarcopenia and hypoalbuminemia on overall survival in esophageal cancer: a retrospective single-center study. Oncology Votavova K, Lohynska R, Drbohlavova T, Pala M, Rybkova M, Pechacova Z. PMID: 42832482 [PubMed - as supplied by publisher]
	A Comparative Study of the Acute Toxicities of Three-Dimensional Conformal Radiotherapy (3D-CRT) Versus Intensity-Modulated Radiotherapy (IMRT) in Locally Advanced and Inoperable Oral Cavity Cancer. Cureus Rahamat Ullah M, Sarkar UK, Hoque SMA, Sarker NK. PMID: 42830812 [PubMed]
	Institutional modified post esophagectomy care protocol offers improved perioperative outcomes - a single-center propensity score matched analysis. World J Surg Oncol Hillebrecht HC, Bührle A, Wang J, Hoeppner J, Diener MK, Fichtner-Feigl S, Hipp J, Kuvendjiska J. PMID: 42829442 [PubMed - indexed for MEDLINE]
	Bispecific antibody-drug conjugates in cancer: therapeutic-window determinants, tumour-immune interactions, and clinical translation. Front Immunol Li Y, Li Y, Huang R, San ZQ, Ye JF. PMID: 42828171 [PubMed - indexed for MEDLINE]
	Usefulness of 18F-fluorodeoxyglucose positron emission tomography for T1 esophageal squamous cell carcinoma. Medicine (Baltimore) Ryu DG, Choi CW, Kim SJ, Kim SJ, Park SB, Jang JO, Lee CM, Son BS. PMID: 42826281 [PubMed - indexed for MEDLINE]
	Small Intestinal Bacterial Overgrowth Following Gastrointestinal Cancer Surgery: Current Evidence and Future Perspectives. Ann Gastroenterol Surg Aoyama T, Cho H, Yoshikawa T. PMID: 42824673 [PubMed - as supplied by publisher]
	Paraneoplastic dermatomyositis preceding detection of metastatic oesophageal squamous cell carcinoma after prolonged remission following pembrolizumab therapy. BMJ Case Rep Hassan SA, Hazarika K, Rai PK. PMID: 42823142 [PubMed - indexed for MEDLINE]
	Effects of Lymphatic and Venous Invasion Status on Postoperative Prognosis and Metastasis Pattern in Patients With Esophageal Squamous Cell Carcinoma: A Retrospective Cohort Study. World J Surg Kitasaki N, Hamai Y, Ibuki Y, Kishi N, Ohsawa M, Kurokawa T, Okada M. PMID: 42820346 [PubMed - as supplied by publisher]
	Neoadjuvant Chemoradiotherapy for Oesophageal Carcinoma: Real-World Data From Practice Beyond the Chemoradiotherapy for Oesophageal Cancer Followed by Surgery Study (CROSS) Trial. Cureus Devi ND, Jagtap VK, Mahawar R, Synrem O, Kumar S, Nongkynrih A, Lyngkhoi B, Harris C, Ghosh S, Lynser D, Raphael V. PMID: 42819423 [PubMed]
	Low Skeletal Muscle Index Predicts Neoadjuvant Immunochemotherapy Tolerance and Survival in Oesophageal Squamous Cell Carcinoma. J Cachexia Sarcopenia Muscle Huang Y, Chen M, Yang Z, Cai B, Zhang Y, Wang H, Zhang S, Zeng T, Chen C, Zheng B. PMID: 42817217 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 39804

Page 1 de 1991



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité